| Applied Molecular Transport is a clinical-stage biopharmaceutical company utilizing its proprietary technology platform to design and develop a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Co. has two oral biologics in clinical development. Co.'s product candidate, AMT-101, is in Phase 2 development for patients with ulcerative colitis and related inflammatory indications. Co.'s second product candidate, AMT-126 is in Phase 1 development for diseases related to intestinal epithelium barrier function defects. We show 11 historical shares outstanding datapoints in our AMTI shares outstanding history coverage, used to compute AMTI market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AMTI market cap history over the course of time is important for investors
interested in comparing AMTI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AMTI versus a peer is one thing; comparing
AMTI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AMTI can fluctuate over the course of history.
With this page we aim to empower investors researching AMTI by allowing them to research the AMTI market cap history.